Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Change in Inventory (2018 - 2025)

Historic Change in Inventory for UroGen Pharma (URGN) over the last 8 years, with Q3 2025 value amounting to $1.2 million.

  • UroGen Pharma's Change in Inventory rose 69802.63% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $747000.0, marking a year-over-year decrease of 7118.06%. This contributed to the annual value of $3.6 million for FY2024, which is 16364.99% up from last year.
  • Per UroGen Pharma's latest filing, its Change in Inventory stood at $1.2 million for Q3 2025, which was up 69802.63% from -$462000.0 recorded in Q2 2025.
  • In the past 5 years, UroGen Pharma's Change in Inventory registered a high of $1.6 million during Q4 2024, and its lowest value of -$1.6 million during Q1 2025.
  • In the last 5 years, UroGen Pharma's Change in Inventory had a median value of $199000.0 in 2024 and averaged $381368.4.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 160000.0% in 2023, then tumbled by 33216.08% in 2025.
  • Quarter analysis of 5 years shows UroGen Pharma's Change in Inventory stood at $1.0 million in 2021, then plummeted by 127.64% to -$283000.0 in 2022, then surged by 337.1% to $671000.0 in 2023, then skyrocketed by 143.37% to $1.6 million in 2024, then fell by 25.72% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, -$462000.0 for Q2 2025, and -$1.6 million during Q1 2025.